A decreased risk was observed among high adherent patients (PDC > 80%) and current users of BPs and SR, but the results did not reach statistical significance [BP, PDC > 80%: odds ratio (OR) = 0.81, 95% confidence interval (CI): 0.56–1.16; current use: OR = 0.95, 95% CI: 0.81–1.11].
← all excerpts
Bisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy.
1
—
—